Showcasing Collaborative Progress and Incubating Future-Facing Programs
This section presents selected collaborative cases and emerging initiatives that illustrate how NBIIC-HI connects research, innovation, institutional partnership, and translational opportunity.
Case studies highlight collaborative activities with identifiable academic, technical, or institutional outputs.
Emerging initiatives represent early-stage platforms and programs being incubated, structured, or expanded through the NBIIC-HI international collaboration network.
Selected cases demonstrate how academic collaboration, scientific outputs, interdisciplinary expertise, and international networks may form the foundation for longer-term innovation and translation.
From Academic Collaboration to Translational Opportunity
This case highlights collaborative scholarly activity involving the International Institute of Synthetic Biology — Canada, NBIIC-HI, and researchers associated with Tianjin University of Science and Technology. The collaboration focuses on synthetic biology, peptide engineering, non-canonical amino acids, and the development of protease-resistant peptide systems with potential relevance to biotechnology and therapeutic innovation.
Engineering Protease-Resistant Peptides via Non-Canonical Amino Acids: Design Strategies and Biosynthetic Advances.
Bioengineering-Basel. 2026.
View ArticleResearch Area: Protease-resistant peptides; non-canonical amino acids; peptide engineering; peptide therapeutics; synthetic biology; biosynthetic engineering.
Protease-resistant peptide engineering may contribute to future applications in therapeutic development, biomaterials, biocatalysis, molecular delivery, and research-oriented biotechnology platforms. The case illustrates how academic research and publication development can establish a scientific foundation for subsequent technology evaluation, interdisciplinary collaboration, and translational program development.
Future development will depend on scientific validation, institutional participation, available technical capabilities, and appropriate collaboration resources.
From Collaborative Project Design to Regulatory Preparation and Regional Implementation
Collaboration Model: Enterprise–Academic Collaboration
Project Status: Active
Focus Area: Organoid NAMs, Nonclinical Drug Evaluation, Regulatory Science, and Technology Implementation
This selected case presents an active enterprise–academic collaboration focused on the validation and application of organoid-based New Approach Methodologies (NAMs) in nonclinical drug evaluation.
The project brings together an academic or research team, a China-based enterprise partner, and NBIIC-HI within a structured framework covering method development, application-scenario definition, validation planning, regulatory preparation, and regional implementation.
The project has been launched and has entered the stage of defining the intended context of use, assessing technical readiness, allocating responsibilities, and preparing supporting application materials.
Academic or Research Team
Responsible for establishing or optimizing the organoid technology platform, defining the proposed application context, developing the methodological framework, designing the validation strategy, and providing relevant technical documentation and research data.
Enterprise Partner
Responsible for regional coordination, technical filing, application-scenario development, implementation planning, and the operational conditions required for subsequent technology deployment.
NBIIC-HI
Responsible for collaboration coordination, expert engagement, project structuring, research-plan development, application-material support, and international academic collaboration.
The project is being structured with reference to relevant regulatory-science pathways for NAMs in China, including applicable requirements associated with the CDE PIONEER Plan.
A collaboration structure has been established, with the academic or research team leading the technical and methodological work, the enterprise partner coordinating regional implementation, and NBIIC-HI providing project coordination and academic support.
Current activities include application-scenario assessment, evaluation of the existing organoid technology system, allocation of work packages, preparation of application materials, and development of the validation and implementation pathway.
The collaboration is expected to generate:
This case demonstrates how an emerging biomedical methodology can be developed into a structured, multi-party project connecting academic expertise, enterprise implementation, regulatory preparation, and international collaboration.
It also illustrates NBIIC-HI’s role in translating scientific concepts into clearly defined work packages, coordinated partnerships, submission-ready project structures, and practical implementation pathways.
This case study includes only information authorized for public disclosure. The identities of certain participating parties, together with confidential technical, commercial, application, and project materials, have been omitted or generalized in accordance with applicable confidentiality obligations.
NBIIC-HI supports the early development of scientific and innovation initiatives that may evolve into dedicated research programs, collaborative platforms, joint centres, or independent organizations.
These initiatives are developed progressively according to scientific maturity, institutional support, collaborative participation, and available resources.
The International Institute of Synthetic Biology — Canada (IISB) is an emerging synthetic biology initiative currently incubated and supported through the NBIIC-HI international collaboration platform.
IISB is being developed as a specialized platform for international research collaboration, talent connection, academic exchange, and translational opportunities in synthetic biology and biomanufacturing.
Potential areas of interest include microbial engineering, metabolic pathway development, non-canonical amino acids, enzyme and biosynthesis platforms, engineered biological systems, and research-oriented biomanufacturing.
IISB remains under development, and specific programs and partnerships will be introduced progressively as its scientific and institutional network expands.
Collaborative opportunities involving computational biology, medical data analysis, predictive modelling, digital tools, and responsible artificial intelligence applications in healthcare and biomedical research.
Developing programs connecting molecular mechanisms, biomarkers, patient stratification, therapeutic response, clinical evidence, and personalized healthcare strategies.
Emerging opportunities involving nanomedicine, biomaterials, controlled delivery, regenerative medicine, molecular imaging, and therapeutic technology development.
NBIIC-HI welcomes discussions with researchers, universities, research institutions, clinical teams, technical platforms, and innovation partners seeking to develop new interdisciplinary initiatives or expand existing research and translational programs through an international collaboration platform.
Submit the form and any permitted supporting documents to: admin@nbiic.ca
Suggested subject line: Research Collaboration Proposal – [Institution / Project Title]
